Abstract. Monoclonal antibodies were prepared against the trisaccharide Galal-3Galpl-4GlcNAc, a sequence which occurs on the surface of Ehrlich ascites tumor cells as well as in thyroglobulin, laminin and a variety of other proteins. This was accomplished by immunizing BALB/c mice with the fraction of Ehrlich cell membrane glycoproteins obtained by affinity chromatography on a Griffonia simplicifolia I (GS I) column which selectively binds a-D-galactosyl-terminated structures. Detection of Galal-3Galbl-4GlcNAc-specific antibodies was accomplished by employing glycoproteins containing the trisaccharide sequence; fusion with spleen cells from an immunized mouse was accomplished in the presence of polyethylene glycol (PEG1500). An enzyme-linked immunosorbent assay (ELISA) system was used to identify two clones (2.10G and 6.8E), which recognized the desired trisaccharide conjugate. These clones also recognized a thyroglobulin fraction isolated by GS I affinity chromatography and murine laminin, both of which possess the Galal-3Galpl-4GlcNAc sequence. Inhibition of antibody-trisaccharide reactivity, examined employing an ELISA assay, revealed that two trisaccharides, Galal-3Galpl-4GlcNAc/Glc, were the best inhibitory haptens; Galpl-4GlcNAc (LacNAc), Galal-3Gal and Galpl-4Glc (lactose) were poor inhibitors. Indirect immunofluorescence staining of unfixed Ehrlich cells using the monoclonal antibody at 4 O C revealed fluorescence over the entire cell surface. Indirect immunogold labeling of semithin and ultrathin sections of aldehyde fixed and Lowicryl K4M-embedded Ehrlich cells resulted in specific labeling of the cell surface and internal structure. Immunoblot analysis revealed that removal of the agalactosyl residues of laminin by a-galactosidase abolished reactivity with the monoclonal antibodies. The availability of this antibody, which belongs to the IgM family of immunoglobulins, now makes possible the detection of this sugar sequence on cells and tissue sections, as well as on glycoproteins in solution.
Introduction
The galactose al-3 galactose Dl-4 N-acetylglucosamine (Gala 1-3GalPl4GlcNAc) oligosaccharide structure has been reported to be present on cell-membrane proteins of bovine thyroid cells (Edge and Spiro 1985) , murine Ehrlich ascites tumor cells (Eckhardt and Goldstein 1983b) , murine lymphoma cells (Cummings and Kornfeld 1984) , murine NIH 3T3 fibroblasts (Santer et al. 1989 ) and bovine thyroglobulin (Cummings and Kornfeld 1982; Dorland et al. 1984; Spiro and Bhoyroo 1984) . This structure does not normally occur on human cells and tissues nor on human thyroglobulin (Peters and Goldstein 1979; Galili et al. 1988 ). Galili and coworkers (1988) have reported that humans produce large amounts of a natural IgG antibody that interacts with a-galactosyl-containing oligosaccharide structures on mammalian glycoconjugates, and that this antibody (anti-Gal) interacts specifically with synthetic Galal3GalDl-4GlcNAc (Galili et al. 1984 (Galili et al. , 1985a Davin et al. 1987; Avila et al. 1989) . It was argued that abnormal expression of Galal-3Galpl4GlcNAc residues on human glycoproteins may result in anti-Gal-mediated autoimmune processes (Thall and Galili 1990) . Mice were immunized with rabbit erythrocytes and a monoclonal antibody (Gal-13) was raised which reacted with the neoglycoprotein Galal-3GalP 1-4GlcNAc-BSA and Galal-3GalDl4GlcNAcD 1-3GaP1-4GlcD 1-1 Ceramide (Galili et al. 1987) . Gil and coworkers (1990) prepared monoclonal IgM antibody (A10) with specificity to Ehrlich ascites tumor cell surface carbohydrates but did not characterize its specificity. Further occurrence of the Galal-3GalD1-4GlcNAc carbohydrate structure was reported by Randle (1982 Randle ( , 1983 . The monoclonal antibody 2C5, which had been raised to PI3 embryonic carcinoma, was shown to react with embryonic and extraembryonic endoderm, thymus and the female reproductive tract. Varani and coworkers (Varani et al. 1983a, b) have shown that the expression of a-D-galactosyl residues on the cell surface is strongly correlated with the metastatic potential of murine fibrosarcoma cells, using the Grzfonia simplicifolia I-B4 isolectin. When these cells were treated with anti-blood type B antisera, the selected cells, lacking terminal a-linked galactosyl groups were also poorly metastatic. Addition of the glycoconjugate, laminin, restored the metastatic property. In this study, we have immunized BALB/c mice with plasma membrane glycoprotein isolated from Ehrlich ascites tumor cell and prepared and characterized a monoclonal antibody, which recognized the Galal-3Galpl4GlcNAc carbohydrate trisaccharide epitope. The monoclonal antibody was employed to detect this structure on Ehrlich cells and on several glycoproteins.
Materials and methods

Materials
The following materials were obtained commercially: Freund's complete adjuvant and Freund's incomplete adjuvant (Difco Laboratories, Detroit, Mich., USA); coffee bean a-galactosidase (Boehringer Mannheim, Indianapolis, Ind., USA) glutaraldehyde, vacuum distilled (Fluka, Buchs, Switzerland); paraformaldehyde and tetrachloroauric acid (Merck, Darmstadt, Germany). Affinity-purified rabbit anti-mouse IgG (L&H) (Jackson ImmunoResearch Laboratories, West Chester, Pa., USA) was complexed with 8 nm gold particles (Lucocq and Baschong 1986) . Galpl4GlcNAc (LacNAc) and Galp14GlcNAc-BSA conjugate were available from previous studies. Galal-3Galp14GlcNAc-p-0-(CH,),COOH and Galal-3Gal~lb4GlcNAc-Synsorb were the gift of Murray Ratcliffe of Chem Biomed (Edmonton, Canada). The Galal-3Galpl4Glc-NAc-bovine serum albumin (BSA) conjugate was prepared by Nike Plessaas in our laboratory; a second sample was a gift of Murray Ratcliffe.
Isolation of Ehrlich cell plasma membrane glycoprotein
Ehrlich ascites tumor cells were maintained by weekly intraperitoneal injection of outbred CD-1 mice (Charles River, Portage, Mich., USA) with 0.6 ml of ascites fluid. For experimentation, cells were harvested 8 or 9 days after transfer and washed. Plasma membrane glycoproteins were prepared as previously described (Eckhardt and Goldstein 1983a) .
Preparation of Galal-3Galpl-4GlcNAc-enriched bovine thyroglobulin
Bovine thyroglobulin, enriched for Galal-3Galpl4GlcNAc residues, was isolated from a commercial preparation of bovine thyroglobulin (Sigma Chemical Co., St Louis, Mo., USA) on a GS I-Sepharose column (1.5 x 21 cm). Bovine thyroglobulin in solution was passed through a GS-I column. After extensive washing with phosphate-buffered saline (PBS), pH 7.5, the bound material was eluted with 10 mM methyl a-galactoside (Shibata et al. 1982; Spiro and Bhoyroo 1984; Thall and Galili 1990) .
Immunization of animals
Female BALB/c mice (5 to 8 weeks old) were immunized by intraperitoneal injection with isolated a-D-galactopyranosyl (a-DGa1p)-containing Ehrlich cell plasma membrane glycoproteins.
Cell fusion
Cell fusion was carried out with spleen cells from an immunized mouse (3 days after the final antigenic boost), following the method of Galfre et al. (1977) and McKearm (1980) . Briefly, murine spleen cells (1 x lo2) were fused with murine myeloma cells (2 x lo7) in polyethlene glycol (PEG1500, Boehringer Mannheim, Indianapolis, Ind., USA). The fused cells were plated into 96-well plates and cultured in HAT-Iscove's Modified Dulbecco's Medium (Gibco BRL, Grand Island, N.Y., USA) at 37' C in a 5% CO, incubator.
Screening
Screening of hybrid cells was conducted initially by enzyme-linked immunosorbent assay (ELISA) with a Galal-3Galpl4GlcNAc-BSA conjugate and Galal-3Galpl4GlcNAc-enriched bovine thyroglobulin adsorbed onto 96-well plates (Nunc, Naperville, Ill., USA). Antigen glycoproteins (10 mg/ml in 0.5 M carbonate buffer, pH 9.5) were bound to microtiter plates by overnight incubation at 4" C. The wells were washed with PBS and subsequently incubated with PBS-1% BSA for 1 h at room temperature in order to block nonspecific binding. After washing with PBS-0.05% BSA, the hybridoma cell culture supernatant solution was added and incubated for 1 h at room temperature. Plates were washed with PBS-0.05% Tween and incubated with a dilution (1 500) of an anti-mouse Ig-antibody Fab fragment from sheep conjugated with alkaline phosphatase (Boehringer Mannheim, Indianapolis, Ind., USA) Following washing, a p-nitrophenyl phosphate substrate solution (1 mg/ml, Sigma 104 phosphatase substrate) was added and the color allowed to develop for 30 min. The enzymatic reaction was quenched with 3 N NaOH and the absorbance read at 405 nm. Colonies showing reactivity towards the above carbohydrates were cloned three times by limiting dilution using macrophages as feeder layers, identifying wells where a single clone could be assured microscopically. Stable cultures of antibody-producing hybridomas were expanded and monoclonal antibodies produced in pristane-treated BALBIc mice.
Pur@cation of monoclonal antibodies
Cell-free ascites fluid was applied to a column of Galal-3Galpl-4GlcNAc-Synsorb (0.6 x 4.0 cm). Before applying the sample, the column was eluted by PBS-1% BSA followed by PBS. Elution of antibodies was achieved by passing 0.1 M glycine-hydrochloric acid buffer, pH 2.5, as described previously (Lapresle and Webb 1965; Lapresle and Goldstein 1969; Hudson and Hay 1976) , through the column at 4' C. Eluted fractions were collected and neutralized immediately with solid Tris.
Chromatography of monoclonal antibodies on laminin-Sepharose
The hybridoma culture supernatant was applied to a column of laminin-Sepharose (0.6 x 8.5 cm) and incubated for 1 h. The column was eluted with PBS and bound fractions were eluted with 0.5 M NaCl containing 10 mM Tris buffer, pH 7.5.
Chromatography of monoclonal antibodies on Galanthus nivalis agglutinin (GNA)-Sepharose
The hybridoma culture supernatant fluid was applied to a column of GNA-Sepharose (0.6 x 8.5 cm) and incubated for 1 h. The column was eluted with PBS, followed by 0.5 M methyl a-D-mannoside in PBS at a flow rate of 1 ml/h and fractions were monitored by absorbance at 280 nm. All experiments were conducted at 4' C. (Shibuya et al. 1988 ).
Characterization of monoclonal antibodies
The isotype of monoclonal antibodies was determined by using a Mouse-Typer Isotyping Kit (Bio-Rad Laboratories, Richmond, Calif., USA). To determine the specificity of monoclonal antibodies, we used an inhibition test in microtiter wells. Antigen glycoproteins (10 mg/ml in 0.5 M carbonate buffer, pH 9.5) were bound to microtiter plates by incubating overnight at 4" C. The GS-Ibound thyroglobulin was used as antigen with which to coat the plates, inasmuch as the Galal-3Galpl4GlcNAc structure occurs on bovine thyroglobulin (Cummings and Kornfeld 1982; Dorland et al. 1984; Spiro and Bhoyroo 1984) . The wells were washed with PBS and subsequently incubated with PBS-1 % BSA for 1 h at room temperature in order to block nonspecific binding. After washing with PBS-0.05% Tween, the monoclonal antibody solution (5 pg/ml in PBS) was incubated with inhibitors (monosaccharide, disaccharides, trisaccharides, and glycoproteins). Plates were washed with PBS-0.05% Tween and incubated with a dilution (1 :500) of an anti-mouse Ig-antibody Fab fragment from sheep conjugated with alkaline phosphatase (Boehringer Mannheim). Following washing, a p-nitrophenyl phosphate substrate solution (1 mg/ml, Sigma 104 phosphatase substrate) was added and the color allowed to develop for 30 min. The enzymatic reaction was quenched with 3 N NaOH and the absorbance read at 405 nm.
Indirect immunoJtuorescence of Ehrlich cells
To 50 y1 of a suspension of washed Ehrlich cells in PBS-5% fetal calf serum (FCS; 5 x lo7 cells/ml) was added 50 yl of the monoclonal antibody solution (5 yg/ml in PBS), and the suspension was stirred gently for 30 min at 4" C. In other experiments, non-specific mouse IgM was added to the cell suspension as a negative control. 
Indirect immunogold labeling of Ehrlich cells
A suspension of washed Ehrlich cells in Hanks balanced salt solution was fixed with 2% formaldehyde (freshly prepared from paraformaldehyde) and 0.1 % glutaraldehyde at 37" C for 30 min. The suspension was subsequently washed with PBS twice for 5 min each, treated with 50 m M NH,CI in PBS for 30 min to amidate free aldehyde groups and stored in PBS at 4" C until embedding. For embedding, cells were pelleted and enclosed in 2% agar. Small pieces of agar containing the enclosed cells were dehydrated in graded ethanol at progressively lowered temperature (down to -40" C), infiltrated with Lowicryl K4M at -40" C and polymerized at -40" C by indirect UV-light irradiation as described (Roth 1989; Roth et al. 1981) . Semithin (1 pm thick) and ultrathin sections were prepared and incubated with the monoclonal antibody (5-25 pg/ml) diluted with PBS containing 1 % BSA and 0.05% Tween 20 for 2 h at room temperature. This was followed by two washes with PBS (5 min each) and incubation with gold-labeled rabbit anti-mouse IgG (diluted with PBS containing 1 % BSA, 0.01% Triton X-100 and 0.01% Tween 20 to an OD,,, , , of 0.05-0.1) for 1 h at room temperature. Ultrathin sections were contrasted with uranyl acetate (5 min) and lead acetate (45 s) and examined with a Zeiss electron microscope 910 at 80 kV. Semithin sections were fixed with 1% glutaraldehyde for 20 min, subsequently thoroughly washed with distilled water, air dried and subjected to silver intensification (Roth 1989) . Specificity controls included treatment of sections with coffee bean a-galactosidase, or preabsorption of the monoclonal antibody with Galal-3Galpl4GlcNAc trisaccharide.
PuriJication of laminin
The Engelbreth-Holm-Swarm (EHS) murine sarcoma was grown as a solid tumor in C57B16 female mice (Orkin et al. 1977) . Laminin was isolated from EHS tumor on a GS I-Sepharose affinity column as previously described by Shibata and co-workers (1982) .
Dot immunoblot analysis
An Immobilon-P transfer membrane (Millipore Co., Bedford, Mass., USA) wetted with 100% methanol was placed in deionized water and 10 mM Tris buffer. Laminin (200 pg in 0.2 ml) was incubated for 14 h with 0.4 Units of coffee bean a-galactosidase in 10 mM Tris buffer, pH 6.0. The solutions of laminin (5 pl) and a-galactosidase-treated laminin were blotted onto a membrane and incubated for 1 h at room temperature. Following incubation, blots were washed for 5 min in 10 mM Tris-buffered saline (TBS), pH 7.4, the wash cycle being repeated three times. The blots were then incubated with 1 % BSA in Tris-buffered saline (TBS) for 1 h at room temperature. After washing with 0.05% Tween in TBS, monoclonal antibody solution (5 yg/ml) was added and incubated for 1 h at room temperature. Blots were washed with 0.05% Tween in TBS and incubated with a (1 500) dilution of an anti-mouse Ig-antibody Fab fragment from sheep conjugated with alkaline phosphatase (Boehringer Mannheim). Following washing, a substrate solution containing 5-bromo-4-chloro-3-indolylphosphate p-toluidine and nitroblue tetrazolium (Gibco BRL) was added.
Results
PuriJication of Ehrlich tumor cell plasma membrane
Plasma membranes solubilized in dimethyldecylphosphine oxide (DClOPO) were subjected to affinity chromatography on a GS I-Sepharose column. a-D-Galactosyl-containing glycoproteins were eluted as a single peak from the column with 0.1 M methyl a-D-Galp (Fig. 1) . 
Fraction number
Characterization of monoclonal antibodies
The hybridoma clone 6.8E, isotype IgM, was selected for further study (Fig. 2) . The capacity of the monoclonal antibody to serve as a reagent for detection of Galal3Galpl4GlcNAc residues was determined by ELISA. The assay was based on inhibition of monoclonal antibody binding to Galal-3Galpl-4GlcNAc-enriched bovine thyroglobulin by incubation of the antibody with various oligosaccharides and carbohydrate conjugates (Table 1) . Low concentrations of Galal-3Galpl-4GlcNAc and Galal-3Galpl4Glc were excellent inhibitors of the interaction. Inhibition did not occur when a-Gal-terminated disaccharides and P-Gal-terminated carbohydrates were assayed, i.e. Galal-3Ga1, Galpl4Glc and Galpl-4GlcNAc were extremely poor inhibitors. The binding of monoclonal antibody to Galal-3GalPl-4GlcNAc-enriched bovine thyroglobulin was inhibited by Galal-3Galpl4GlcNAc-containing glycoproteins; this inhibition activity was abolished by treatment with a-galactosidase. These results indicate that monoclonal Reactivity of monoclonal antibodies against laminin antibody 6.8E interacts in a very specific manner with Galal-3Gal~l4GlcNAc epitopes. When the hybridoma
The hybridoma culture supernatant fluid was applied to culture supernatant fluid was applied to a column of a column of laminin-Sepharose and the bound fraction GNA-Sepharose, the bound fraction were eluted as a eluted as a single peak from the column (Fig. 4) . Followsingle peak from the column (Fig. 3) ing the report that terminal, non-reducing a-D-galactosyl units comprise 15.5-19.5% of the total galactosyl content of laminin (Knibbs et al. 1989) , we assayed the reactivity of monoclonal antibodies with laminin using a dot immunoblot procedure. Antigens employed were laminin and a-galactosidase-treated laminin. The results in Fig. 5 demonstrated that our monoclonal antibody did not react with a-galactosidase-treated laminin. Following dialysis against PBS, we applied the a-galactosidase-treated laminin to a GS I-Sepharose column. The agalactolaminin did not react with GS I, indicating the absence of a-D-galactosyl units.
Detection of Galal-3Galpl-4GlcNAc residue of Ehrlich tumor cell surface Fluorescence microscopy of Ehrlich tumor cells incubated with monoclonal antibody revealed intense fluorescence over the entire cell surface (Fig. 6 ). Indirect immunogold labeling of semithin and ultrathin Lowicryl K4M embedded cells also resulted in labeling along the cell surface and internal structures (Figs. 7 and 8) . The intracellular labeling pattern will be reported elsewhere. Under the different conditions of the specificity controls no labeling was observed (data not shown).
Discussion
Eckhardt and Goldstein (1979, 1983a, b) isolated a series of a-D-Galp-containing glycoproteins from Ehrlich ascites tumor cells. The distribution and quantitation of a-D-Galp groups on the cell surface was determined by using the a-D-galactopyranosyl-specific isolectin Grzfinia simplicifolia I-B4 labeled with fluorescein isothiocyanate, ferritin,
propionate. In the present study, we prepared Ehrlich cell plasma membrane glycoproteins in the same manner and immunized BALB/c mice with them. Following cell fusion with spleen cells from an immunized mouse, we obtained hybridomas producing monoclonal antibodies that reacted with glycoproteins containing Galal-3-GalplHGlcNAc epitopes. These monoclonal antibodies were characterized 'by hapten inhibition using ELISA. Two preparations recognized the Galal-3Galpl-4GlcNAclGlc residue. The binding of Gala 1-3Galp 1-4GlcNAc-containing glycoprotein was inhibited by Galal-3GalplMGlcNAc and Galal-3GalplMGlc, but not by GalplHGlcNAc (LacNAc) or GalplMGlc (lactose). Therefore the N-acyl group at the C-2 position of glucose is not necessary for recognition by this antibody. This monoclonal antibody reacted with laminin and Galal-3GalplMGlcNAc-enriched bovine thyroglobulin and also reacted strongly with Ehrlich tumor cells. Recently, clinical interest has focused on the terminal a-galactosyl residues of glycoproteins including laminin. Galili et al. (1984) reported that human antibodies to the Galal-3GalplMGlcNAc structure, normally present in the serum, constituted 1 % of circulating IgG; the epitope itself is not ordinarily expressed on human cells and glycoproteins (Thall and Galili 1990) . However in at least two human disease states, namely metastatic cancer and Chagas' disease, it is thought that these antibodies may participate in defense processes. Human cancer cells often express this epitope (Castronovo et al. 1987) and the antibody will inhibit adhesion of these cells to laminin (Castronovo et al. 1989) . The parasitic trypanosome which causes Chagas' disease also carries the same epitope (Milani and Travassos 1988; Avila et al. 1989) . It has been suggested that laminin may be one of the major a-D-Galp-containing moieties in many tumor cell lines of murine origin (Varani et al. 1983a, b; McCoy et al. 1984) . Knibbs et al. (1989) reported that the Galal-3Galpl-4GlcNAcPl-6 branching structure is present on the oligosaccharide structures of laminin; these investigators also showed that the Ehrlich cell plasma membrane glycoprotein reacted with anti-laminin antibodies when examined by ELISA (Knibbs et al. unpublished observation) . In this study, our monoclonal antibodies reacted with laminin; treatment with a-galactosidase abolished this reaction. Using these monoclonal antibodies, we now plan to investigate the occurrence of the Galal-3-G a l~l 4 G l c N A c epitope in normal and tumor murine and human cells.
